We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
National Vision (EYE) Soars 9.4%: Is Further Upside Left in the Stock?
Read MoreHide Full Article
National Vision (EYE - Free Report) shares ended the last trading session 9.4% higher at $11.90. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11% loss over the past four weeks.
National Vision scored a strong price increase on investors’ optimism surrounding its impending first quarter 2025 financial results, expected to release on May. 14, before the market opens. In the fourth quarter, the company’s adjusted loss per share of 2 cents came narrower than the Zacks Consensus Estimate of 16 cents loss. Meanwhile, revenues topped the consensus mark by 1.4%.
This discount optical retailer and eye care provider is expected to post quarterly earnings of $0.32 per share in its upcoming report, which represents a year-over-year change of +6.7%. Revenues are expected to be $522.46 million, down 3.7% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For National Vision, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on EYE going forward to see if this recent jump can turn into more strength down the road.
National Vision belongs to the Zacks Consumer Products - Staples industry. Another stock from the same industry, Procter & Gamble (PG - Free Report) , closed the last trading session 2.5% higher at $162.32. Over the past month, PG has returned -8.5%.
P&G's consensus EPS estimate for the upcoming report has changed -1.2% over the past month to $1.56. Compared to the company's year-ago EPS, this represents a change of +2.6%. P&G currently boasts a Zacks Rank of #3 (Hold).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
National Vision (EYE) Soars 9.4%: Is Further Upside Left in the Stock?
National Vision (EYE - Free Report) shares ended the last trading session 9.4% higher at $11.90. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 11% loss over the past four weeks.
National Vision scored a strong price increase on investors’ optimism surrounding its impending first quarter 2025 financial results, expected to release on May. 14, before the market opens. In the fourth quarter, the company’s adjusted loss per share of 2 cents came narrower than the Zacks Consensus Estimate of 16 cents loss. Meanwhile, revenues topped the consensus mark by 1.4%.
This discount optical retailer and eye care provider is expected to post quarterly earnings of $0.32 per share in its upcoming report, which represents a year-over-year change of +6.7%. Revenues are expected to be $522.46 million, down 3.7% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For National Vision, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on EYE going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
National Vision belongs to the Zacks Consumer Products - Staples industry. Another stock from the same industry, Procter & Gamble (PG - Free Report) , closed the last trading session 2.5% higher at $162.32. Over the past month, PG has returned -8.5%.
P&G's consensus EPS estimate for the upcoming report has changed -1.2% over the past month to $1.56. Compared to the company's year-ago EPS, this represents a change of +2.6%. P&G currently boasts a Zacks Rank of #3 (Hold).